γ-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Aβ(1-42)-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease

Journal of Neuroscience Research

Volumn 79, Issue 5, 2005, Pages 700-706

  Boyd Kimball, Debra ^a   Sultana, Rukhsana ^a   Mohmmad Abdul, Hafiz ^a   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Amyloid beta peptide; Glutathione

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BUTHIONINE SULFOXIMINE; DNA FRAGMENT; GAMMA GLUTAMYLCYSTEINE ETHYL ESTER; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA DAMAGE; EVALUATION; GLUTATHIONE METABOLISM; MITOCHONDRIAL RESPIRATION; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; CELL COUNT; CELLS, CULTURED; DIPEPTIDES; DNA FRAGMENTATION; DRUG INTERACTIONS; EMBRYO; GLUTATHIONE; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROPIDIUM; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 16444379174     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20394     Document Type: Article

References (31)

1. Abramov AY, Canevari L, Duchen MR. 2003. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23:5088-5095.
2. Anderson ME, Lou JL. 1998. Glutathione therapy: from prodrugs to genes. Semin Liver Dis 18:415-424.
3. Anderson ME, Meister A. 1989. Glutathione monoesters. Anal Biochem 183:16-20.
4. Anderson ME, Powrie F, Puri RN, Meister A. 1985. Glutathione mono-ethyl ester: preparation, uptake by tissues, and conversion to glutathione. Arch Biochem Biophys 239:538-548.
5. Behl C. 1999. Vitamin E and other antioxidants in neuroprotection. Int J Vit Nutr Res 69:213-219.
6. Butterfield DA. 2002. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. Free Rad Res 36:1307-1313.
7. Butterfield DA. 2003. Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. Curr Med Chem 10:2651-2659.
8. Butterfield DA, Lauderback CM. 2002. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Rad Biol Med 32:1050-1060.
9. Butterfield DA, Stadtman ER. 1997. Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 2:161-191.
10. Butterfield DA, Drake J, Pocernich C, Castegna A. 2001. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 7:548-554.
11. Butterfield DA, Castegna A, Lauderback CM, Drake J. 2002a. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23:655-664.
12. Butterfield DA, Pocernich CB, Drake J. 2002b. Elevated glutathione as a therapeutic strategy in Alzheimer's disease. Drug Disc Res 56:328-437.
13. Cooper AJL. 1997. Glutathione in the brain: disorder of glutathione metabolism. In: The molecular and genetic basis of neurological disease. Newton, MA: Butterworth-Heinemann. p 1195-1230.
14. Darzynkiewicz Z, Li X, Gong J. 1994. Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol 41:15-38.
15. Drake J, Kanski J, Varadarajan S, Tsoras M, Butterfield DA. 2002. Elevation of brain glutathione by γ-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J Neurosci Res 68:776-784.
16. Drake J, Link CD, Butterfield DA. 2003a. Oxidative Stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging 24:415-420.
17. Drake J, Sultana R, Aksenova M, Calabrese V, Butterfield DA. 2003b. Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J Neurosci Res 74:917-927.
18. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 11:81-128.
19. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita P, Wu JF, Carney JM, Lovell M, Markesbery WR, Butterfield DA. 1995. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146-2156.
20. Liu R, Choi J. 2000. Age-associated decline in γ-glutamylcysteine synthetase gene expression in rats. Free Rad Biol Med 28:566-574.
21. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. 1997. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68:255-264.
22. Markesbery MR. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Rad Biol Med 23:134-147.
23. Medina S, Martinez M, Hernanz A. 2002. Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine, and beta-amyloid peptide 1-42. Free Rad Res 36:1179-1184.
24. Selkoe DJ. 2001. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3:75-80.
25. Subbarao KV, Richardson JS, Ang LC. 1990. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55:342-345.
26. Uchida K. 2003. 4-Hydroxynonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318-343.
27. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. 2000. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130:184-208.
28. Xie C, Lovell MA, Markesberry WR. 1998. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Rad Biol Med 25:979-988.
29. Yatin SM, Varadarajan S, Link CD, Butterfield DA. 1999a. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42). Neurobiol Aging 20:325-330.
30. Yatin SM, Yatin M, Aulick T, Ain KB, Butterfield DA. 1999b. Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neurosci Lett 263:17-20.
31. Yatin SM, Varadarajan S, Butterfield DA. 2000. Vitamin E prevents Alzheimer's amyloid beta-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J Alzheimers Dis 2:123-131.